RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Who knows what ? When or how? Actually we are two weeks closer to the Pancreatic cancer trial update.
.....You know, the one with Roche, that brought to attention immediately gaining FDA fast track approval & moving the trial to phase 2b?
The same trial that indicated results 3x better than the existing standard of care.
Including one complete remission.
The share price?
I recall Mr. Buck Henry , advised everyone to sell on Friday & buy back in October?
please do some reading. They are expected to announce updates to the panc cancer & other Goblet results, alongside Tecentriq ( Roche), second half of this year.
That could be anytime between now & Dec 31.
Should the additional pancreatic results even come close to the run- in trial? The SP will be well above any spikes we have seen lately.
enjoy you days all...